Abstract: Example photoconductive devices and example methods for using photoconductive devices are described. An example method may include providing a photoconductive device having a metal-semiconductor-metal structure. The method may also include controlling, based on a first input state, illumination of the photoconductive device by a first optical beam during a time period, and controlling, based on a second input state, illumination of the photoconductive device by a second optical beam during the time period. Further, the method may include detecting an amount of current produced by the photoconductive device during the time period, and based on the detected amount of current, providing an output indicative of the first input state and the second input state. The example devices can be used individually as discrete components or in integrated circuits for memory or logic applications.

Abstract: A method for notifying a network domain and an Access Point (AP) are disclosed to overcome the problem that User Equipment (UE) entering the AP cell is notified but a UE leaving the AP cell is not notified. The method includes: the AP receiving a service request message sent by UE; and inserting a preset voice data packet into a user plane before a conversation to indicate the user of the UE a network domain that covers the UE currently, if it is determined that a current signaling connection is a Circuit Switched (CS) connection according to the service request message.

Abstract: A lamp includes a first body and a second body. The first body has a protrusion, a first engaging portion and two ribs. The second body has a second engaging portion which is engaged with the first engaging portion. The second engaging portion has two L-shaped connection slots with which the ribs are engaged. The second body has a first guide path and three second guide path. Two inclined ramps are located in the first guide path so that the protrusion of the first body slides along the inclined ramps to guide the first engaging portion to be engaged with the second engaging portion. The protrusion is restricted by the contact faces of the blocks to restrict that the second body can only be rotated in one direction to engage the ribs with the connection slots.

Abstract: Benzodiazepine dimers having a structure represented by wherein X comprises a heteroaromatic moiety and is as further defined in the application; R1 is and the other variables in formulae (I), (Ia), and (Ib) are as defined in the application. Such dimers are useful as anti-cancer agents, especially when used in an antibody-drug conjugate (ADC).

Abstract: Benzodiazepine dimers having a structure represented by wherein R1 is wherein the variables in formulae (I), (Ia), and (Ib) are as defined in the application. Such dimers are useful as anti-cancer agents, especially when used in an antibody-drug conjugate (ADC).

Abstract: A computer system for parsing bulk message information into intelligent question retrieval models receives text-based data associated with a particular user. The system encodes the word into a context-dependent vector, wherein the context-dependent vector indicates the meaning of the word across a semantic space. The system also identifies within a context-independent database a context-independent vector that is associated with the word. Further, the system generates an objective output by combining the context-dependent vector and the context-independent vector. Further still, the system generates a sentence encoding representation by processing at least a portion of the text-based data through a high-level feature embedded convolutional semantic model to generate numerical representations of questions and answers within the text-based dataset. The sentence encoding representation is generated at least in part based upon the objective output.

Abstract: Devices and methods for preparing oxygen-containing liquid fuel by bio-oil catalytic conversion. A device includes a biomass fast thermal cracking system for preparing bio-oil, a bio-oil oil-water separating system for separating the bio-oil into oil phase bio-oil and water phase bio-oil that is output to an oil phase bio-oil chemical chain hydrogen production system, and a water phase bio-oil catalytic hydrogenation system. The hydrogen production system outputs produced hydrogen to the water phase bio-oil catalytic hydrogenation system to prepare a liquid fuel. A method includes the steps: thermally cracking the biomass to prepare bio-oil, separating the water phase and the oil phase, producing hydrogen from the oil phase bio-oil through a chemical chain method so as to provide a hydrogen source for the water phase bio-oil to carry out two-stage catalytic hydrogenation in a slurry bed, and separating and purifying the hydrogenated products to obtain an oxygen-containing liquid fuel.

Abstract: Methods and systems for detecting defects on a wafer are provided. One method includes altering one or more design clips based on how the one or more design clips will appear in output generated by a wafer inspection process for a wafer. The method also includes aligning the one or more altered design clips to the output generated for the wafer during the wafer inspection process. In addition, the method includes detecting defects on the wafer based on the output aligned to the one or more altered design clips.

Abstract: This disclosure describes a user interface (UI) conceptual model and a data model for quickly and easily developing and managing a GUI. The present methods and systems described herein provide for defining one or more UI elements in the UI conceptual model. The one or more UI elements may further reference one or more model objects in the data model. The one or more model objects may include one or more tasks, which may each be mapped to one or more commands for performing each task, or one or more data items, which may each be mapped to rules or conditions for transforming data. According to embodiments, graphics or functionality of a GUI may be easily and efficiently modified by adding, deleting, or modifying UI elements in the UI conceptual model or by adding, deleting, or modifying referenced model objects in the data model, thereby reducing management and development costs.

Abstract: The invention relates generally to compounds that modulate the activity of TGF?R-1 and TGF?R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Abstract: The present invention relates to nitric oxide (NO)-releasing nail coating compositions, NO-releasing coatings, and methods of using the same, for example, to treat fungal infections of a nail. It is noted that aspects described with respect to one embodiment may be incorporated in different embodiments although not specifically described relative thereto. Provided according to embodiments of the invention are nitric oxide (NO)-releasing nail coating compositions and/or coatings.

Abstract: The present disclosure provides a thin film transistor, an array substrate, a display panel and a display device. The thin film transistor comprises a gate layer, a source and a drain located on the gate layer, and an active layer located on the source and the drain. The active layer is electrically connected to the source and the drain. The active layer comprises two sides arranged in parallel, and each side forms an acute angle of 45° with a face of the drain facing the source.

Abstract: Graphene is used as an interfacial layer to grow Si and other semiconductors or crystalline materials including two-dimensional Si and other structures on any foreign substrate that can withstand the growth temperature without the limitation matching condition typically required for epitaxial growth.

Abstract: The present disclosure provides a shift register circuit, which includes a first switch unit connecting an input end to a first node when a positive-phase clock signal is at a first level; a second switch unit applying a negative-phase clock signal to an output end when the first node is at the first level; a positive feedback unit enabling the second node to be at a second level when the first node is at the first level and enabling the first node to be at the second level when the second node is at the first level; a third switch unit enabling a third node to be at the first level when the positive-phase clock signal is at the first level; a fourth switch unit connecting the second node to the third node when the negative-phase clock signal is at the first level; and a fifth switch unit.

Abstract: Disclosed are a method of determining an HPV integration site in a genome of a human tissue sample and a system thereof. The method comprises: subjecting genome DNA of the human tissue sample to a first sequencing, to obtain a sequencing result; determining DNA fragments containing both HPV sequence and human genome sequence, based on the sequencing result; determining a pair of amplification primers based on the DNA fragments containing both HPV sequence and human genome sequence, subjecting the genome DNA of the human tissue sample to PCR amplification using the pair of amplification primers, to obtain PCR product; and subjecting the PCR product to a second sequencing, to determine the integration site in a genome of the human tissue sample. The method is easy to be operated with low cost, high efficiency and excellent repeatability, which may be used to detect all HPV genotypes one time, and may rapidly and accurately determine detailed sequence information and integration site.

Abstract: Macrocyclic benzodiazepine dimers having a structure represented by formula I where A and B are independently according to formulae Ia or Ib and the other variables in formulae I, Ia, and Ib are as defined in the application. Such dimers are useful as anti-cancer agents, especially when used as the drug component in an antibody-drug conjugate (ADC).

Abstract: A display panel and a manufacturing method thereof and a display device are provided. The display panel includes an array substrate and an opposed substrate that are opposite to each other, and a liquid crystal layer located between the array substrate and the opposed substrate. The display panel includes a display area and a non-display area, a phase shift layer is disposed at the non-display area of the array substrate, and the phase shift layer is configured to shift a phase of light passing through the phase shift layer. The display panel is used to solve color cast problem when a TFT-LCD displays a pure color, which is caused by cross color when the display panel is viewed at a side angle.

Abstract: A refrigerator has a storage compartment, a door for opening and closing the storage compartment, an ice-making machine and an ice storage compartment. The ice-making machine is used to produce an ice cube. The ice storage compartment is disposed below the ice-making machine, so as to accommodate an ice cube. The ice storage compartment has a discharge port. A movable blocking member and an ice-crushing cutter are located in the ice storage compartment. A distributor is located on the door and used to distribute the ice cube from the ice storage compartment to the outside. The ice storage compartment further includes an opening and closing mechanism for opening or closing the discharge port. Because the discharge port of the ice storage compartment can be closed, the ice-crushing cutter disposed above the discharge port will not be unconsciously touched, and a user is avoided from being hurt by the ice-crushing cutter.

Abstract: The invention provides compounds of the Formula (I) or a pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R2, R4, Ra, and the subscripts m, p, and q are as described herein. The compounds or their pharmaceutically acceptable salts can modulate the body's production of cyclic guanosine monophosphate (“cGMP”), and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention also provides pharmaceutical compositions which comprise compounds of Formula (I) or pharmaceutically acceptable salts thereof. The invention also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose.